Search for Clinical Trial Results
Adult T-cell Leukemia/lymphoma - 310 Studies Found
Status | Study |
Recruiting |
Study Name: High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant Condition:
Date: 2013-09-03 |
Terminated |
Study Name: TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients Condition: Chronic Myelogenous Leukemia Date: 2006-12-22 Interventions:
|
Recruiting |
Study Name: Ruxolitinib for Adult T-Cell Leukemia Condition:
|
Recruiting |
Study Name: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma Condition:
|
Completed |
Study Name: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia Condition: Leukemia, Adult T-Cell Date: 2005-07-07 Interventions: Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |
Recruiting |
Study Name: Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma Condition:
|
Recruiting |
Study Name: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Condition:
Date: 2015-08-05 Interventions:
|
Completed |
Study Name: Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac Condition:
Date: 1999-11-03 Interventions: Drug: Yttrium-90 radiolabeled anti-Tac antibody |
Completed |
Study Name: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load Condition: Human T-cell Leukemia Virus Type 1 Infection Date: 2012-01-25 Interventions: Drug: Raltegravir Raltegravir 400 mg po bid |
Completed |
Study Name: Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma Condition: Lymphoma Date: 2002-07-08 Interventions:
|